Page last updated: 2024-11-05

vesnarinone and Glioma

vesnarinone has been researched along with Glioma in 1 studies

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research Excerpts

ExcerptRelevanceReference
"The growth and morphological change of human glioma transplanted subcutaneously and intracerebrally to nude mice with orally administered vesnarinone, 3,4-dihydro-6-[4-(3,4-dimethoxy-benzoyl)-1-piperazinyl]-2(1H)-quinolinon e, were examined."7.70Apoptosis-inducing activity and growth suppression by vesnarinone on human glioma transplanted in nude mice. ( Adachi, M; Hori, T; Kawai, K; Nakai, S; Tanaka, S, 1999)
"The growth and morphological change of human glioma transplanted subcutaneously and intracerebrally to nude mice with orally administered vesnarinone, 3,4-dihydro-6-[4-(3,4-dimethoxy-benzoyl)-1-piperazinyl]-2(1H)-quinolinon e, were examined."3.70Apoptosis-inducing activity and growth suppression by vesnarinone on human glioma transplanted in nude mice. ( Adachi, M; Hori, T; Kawai, K; Nakai, S; Tanaka, S, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, S1
Kawai, K1
Nakai, S1
Adachi, M1
Hori, T1

Other Studies

1 other study available for vesnarinone and Glioma

ArticleYear
Apoptosis-inducing activity and growth suppression by vesnarinone on human glioma transplanted in nude mice.
    Neurological research, 1999, Volume: 21, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Dose-Response Relationship, Drug; Drug A

1999